Title of Collaborative Activity: |
SARS-CoV-2 Interagency Group on Resistance to Medical Countermeasures (MCMs) |
Description of Collaborative Activity: |
SARS-CoV-2 interagency Working Group with vaccine, therapeutics, and diagnostics subgroups |
Type of Collaborative Activity: |
Committee, Advisory Group, or Work Group
|
Year the Collaborative Activity Originated: |
2021 |
NIH Participating Institutes/Centers/Office of the Director: |
|
HHS Agency Collaborators on this Activity: |
ASPR, CDC, FDA |
